Solution for analyzing DNA-associated diseases in sight

Maia Genomics develops AI software to analyze and interpret human DNA and investigate genes associated with rare genetic diseases, pharmacogenomics, and cancer. This software can help identify rare genetic diseases before symptoms appear.

Animal’s social behavior’s effect on epidemics

When a virus or another parasite infects humans or animals, their behaviour influences whether and how an epidemic develops. But how does our behavior influence the emergence and evolution of epidemics? Jessica Stephenson at Stockholm University studies the dynamics between guppy fish and their parasites.

Future's Sustainable Innovation

Sweden's top profiles in innovation, politics, business, academia, and society gather every year to discuss how innovation and business development can best be promoted. The industry organization Swedish Incubators & Science Parks (SISP) arranges the meeting. This year, we met in Luleå, focusing on the green transition and how innovation can shape the sustainable societies of the future.

A national effort to implement precision medicine

RICHARD ROSENQUIST BRANDELL: Recent advances in precision medicine are revolutionizing healthcare. In several disease areas, patients benefit from refined diagnostics and individually tailored treatments. For the next step, Sweden needs to come together as one voice for developing and implementing precision medicine.

AI in healthcare: experiences of product development and implementation

-

We have all noticed the progress of Artificial intelligence at all levels of our society in recent years. Also, in healthcare, AI tools are now being used in clinical practice. How can the pioneers' experiences help others who aim to improve healthcare practice with the help of AI? 

Cyber security and life science: How does the new NIS2 directive affect your business?

-

IT attacks are becoming increasingly common and pose a growing threat to public organizations and companies. What requirements are placed on cyber security for life science companies? How does the new EU directive NIS2 affect companies developing products for healthcare? How do you get started mapping security risks and working with measures effectively? 

Subscribe to